• UM Eye Research Centre (UMERC)
  • ra.umerc@um.edu.my
logo
logo

Research Grants

2024 Grants

No Project Title PI Name Co-Researcher Project No Project Start Date Project End Date Grant Type Fund Source Project Level Project Allocation (RM)
1 Diagnostic Kit for Ocular Disease Prof Dr Tengku Ain Fathlun Tengku Kamalden AP Dr Sujaya
Dr Nur Musfirah Mahmud
7/11/2024 Goverment Grant Ministry of Economy National 239,118.65
2 Efficacy of topical diquafosol sodium 3% preservative free in treating dry eye disease caused by meibomian gland dysfunction Dr Lim Yi Wen AP Dr Sujaya 1/12/2024 30/11 2026 Internal Grant Universiti Malaya Universiti 50,000
3 Elucidating the role of biomarkers for diabetes Dr Nur Musfirah Mahmud Prof Tengku Ain Fathlun Tengku Kamalden
Prof Dr Lim Lee Ling
Dr Mohd Shafiq Azanan
1/12/2024 30/11/2026 Internal Grant Universiti Malaya Universiti 49,890

2023 Grants

UMRG / INTERNAL GRANTS
NO. PROJECT TITLE SOURCES RECIPIENTS

1

Physical Activity and Psychological status after Falls UM Nurliza Khaliddin
 
EXTERNAL
No. PROJECT TITLE SOURCES RECIPIENTS

1

Retinopathy of Prematurity Outcomes in Malaysia University of Sydney Chaw May May

2

The Role Of Pancreatic β Cell-specific Exosomal Micrornas In Pathogenesis Of Diabetic Macular Edema Bayer Fund Tengku Ain Fathlun Tengku Kamalden

3

Isolating And Characterizing Exosomal Micrornas In Tear Fluid In Diabetic Retinopathy Alcon Research Institute Tengku Ain Fathlun, Tengku Kamalden, Nurliza Khaliddin, Nor Fadhilah Mohamad
 
CLINICAL RESEARCH (UNDER CLINICAL INVESTIGATION CENTRE, CIC)
No. PROJECT TITLE SOURCES RECIPIENTS

1

RGH MD25

A Double-Blind, Placebo-Controlled, Randomized Withdrawal, Multicenter Clinical Trial Evaluating The Efficacy, Safety, And Tolerability Of Cariprazine In A Dose-Reduction Paradigm In The Prevention Of Relapse In Bipolar I Disorder Patients Whose Current Episode Is Manic Or Depressive, With Or Without Mixed Features

Allergan Malaysia Sdn. Bhd. Amir Samsudin (Co-Researcher)

2

RGH MD24

A Double-Blind, Placebo-Controlled, Randomized Withdrawal, Multicenter Clinical Trial Evaluating The Efficacy, Safety, And Tolerability Of Cariprazine In A Dose-Reduction Paradigm In The Prevention Of Relapse In Patients With Schizophrenia

Allergan Malaysia Sdn. Bhd. Amir Samsudin (Co-Researcher)

3

MK-3475-B15

A phase 3, Randomized, Open-label Study to Evaluate Perioperative Enfortumab Vedotin Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Gemcitabine and Cisplatin in Cisplatin-eligible Participants with Muscle-invasive Bladder Cancer (KEYNOTE-B15/EV 304)

Merck Sharp & Dohme (M Sdn Bhd) Nor Fadhilah Mohamad (Co-Researcher)

4

CDRB436J12301

A Randomized, double-blind, Placebo-controlled Phase 3 study to Evaluate the Efficacy and Safety of Dafrafenib plus Trametinib in Previously Treated Patients with Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E mutation-positive Differentiated Thyroid Cancer

Novartis Corporation (Malaysia) Sdn Bhd Nor Fadhilah Mohamad (Co-Researcher)
BKP SPECIAL
NO. PROJECT TITLE SOURCES RECIPIENT GRANT NUMBER

2

Ocular Disease And The Development Of A Self-Administered Tool For The Detection Of Ocular Involvement In Patients With Psoriasis And Psoriatic Arthritis

UM Research Fund Assistance (BKP)

Dr Sujaya Singh

Bk035-2018

TOTAL: RM 40,200.00
 
INTERNATIONAL GRANT
NO. PROJECT TITLE SOURCES RECIPIENT

1

The Role Of Pancreatic β Cell-specific Exosomal Micrornas In Pathogenesis Of Diabetic Macular Edema

Global Ophthalmology Awards Program – BAYER

A/P Dr Tengku Ain

2

Isolating And Characterizing Exosonmal Micrornas In Tear Fluid In Diabetic Retinopathy

Alcon Research Institute ARI Young Investigator Grant

A/P Dr Tengku Ain

TOTAL: RM 533,818.38

Last Update: 04/12/2024